The U.S. Agency for International Development (USAID), in partnership with Uzbekistan’s Ministry of Health and Abt Associates, is launching TB-Free Uzbekistan, a five-year initiative investing $18 million to provide comprehensive support services and increase access to key tuberculosis (TB) services across the country.
Uzbekistan is dealing with high rates of multidrug-resistant TB, which pose a significant threat to Uzbekistan’s public health system and the country’s economic development. Uzbekistan is making steady progress, but TB remains one of its most pressing public health threats. According to Uzbekistan’s Ministry of Health, in 2022, 8% of new TB cases in the country had resistance to two of the most commonly used and effective treatment drugs.
USAID leads the U.S. Government’s global TB efforts, and has been a partner to the Government of Uzbekistan in the fight against TB. As the world’s largest bilateral donor, USAID uses new innovations and research to accelerate efforts to end TB.
USAID had a robust presence at the United Nations high-level meeting on TB on September 22nd, 2023. USAID’s Assistant Administrator for Global Health, Atul Gawande, participated in multiple events, culminating in a high-level meeting at which he launched the Global Accelerator to End TB Plus, an enhanced package of interventions that will accelerate the development of strategies to achieve a more accountable, responsible, and inclusive TB response.
From 1993 to 2023, the total amount of the U.S. Government assistance to Uzbekistan in health has totaled over $155 million of which nearly $60 million was focused on TB mitigation.
